Both in Biotechnology
Tenaya Therapeutics vs Neumora Therapeutics
Over the past year TNYA returned −74.5% and NMRA returned −87.8%; their daily moves had a correlation of 0.09.
TNYA −74.5% NMRA −87.8%Growth of $1, one year, split-adjusted
| Metric | TNYA | NMRA |
|---|---|---|
| Price | $0.3674 | $0.3672 |
| Market cap | $83.7M | $69.0M |
| Today | −7.78% | −5.43% |
| 1 month | −35.1% | −33.2% |
| 6 months | −47.9% | −85.0% |
| Year to date | −48.4% | −79.5% |
| 1 year | −74.3% | −85.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −3909.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 62.7× | — |
| Net cash | $78.1M | $63.9M |
| Dividend yield | — | — |
| Volatility (60d) | 78.0% | 102.6% |
| Short % of float | 13.1% | 6.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).